We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-21.98%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
$0
Cap. Flow
-$63.6K
Cap. Flow %
-0%
Top 10 Hldgs %
13.08%
Holding
3,173
New
–
Increased
3
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
+$51.9K
2
OVV icon
Ovintiv
OVV
+$14.7K
3
VANI icon
Vivani Medical
VANI
+$119

Top Sells

Rank Stock Value
1
BIP icon
Brookfield Infrastructure Partners
BIP
+$78.8K
2
TU icon
Telus
TU
+$37K
3
ODFL icon
Old Dominion Freight Line
ODFL
+$14.5K
4
BBBY
Bed Bath & Beyond
BBBY
+$11

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LGND icon
951
Ligand Pharmaceuticals
LGND
$5.76B
$256K ﹤0.01%
3,948
– –
LPX icon
952
Louisiana-Pacific
LPX
$5.06B
$256K ﹤0.01%
8,685
– –
XRAY icon
953
Dentsply Sirona
XRAY
$2.68B
$256K ﹤0.01%
4,531
– –
AAON icon
954
Aaon
AAON
$7.3B
$255K ﹤0.01%
7,745
– –
AL
955
DELISTED
Air Lease Corp
AL
$254K ﹤0.01%
5,367
– –
MSEX icon
956
Middlesex Water
MSEX
$1.07B
$254K ﹤0.01%
4,000
– –
VC icon
957
Visteon
VC
$2.79B
$252K ﹤0.01%
2,918
– –
EPR icon
958
EPR Properties
EPR
$4.75B
$251K ﹤0.01%
3,560
– –
PINC
959
DELISTED
Premier
PINC
$251K ﹤0.01%
6,642
– –
ARLP icon
960
Alliance Resource Partners
ARLP
$3.34B
$250K ﹤0.01%
23,135
– –
MED icon
961
Medifast
MED
$109M
$250K ﹤0.01%
2,290
– –
BSX icon
962
Boston Scientific
BSX
$69.5B
$249K ﹤0.01%
5,511
– –
NVCR icon
963
NovoCure
NVCR
$1.73B
$249K ﹤0.01%
2,969
– –
BAC.PRY.CL
964
DELISTED
BANK OF AMERICA CORPORATION Depositary Shares representing a 1/1,000 th interest in a share of 6.500
BAC.PRY.CL
$249K ﹤0.01%
10,000
– –
HR icon
965
Healthcare Realty
HR
$7.28B
$248K ﹤0.01%
8,195
– –
KWR icon
966
Quaker Houghton
KWR
$2.79B
$248K ﹤0.01%
1,508
– –
WNS
967
DELISTED
WNS Holdings
WNS
$248K ﹤0.01%
3,756
– –
FXI icon
968
iShares China Large-Cap ETF
FXI
$4.37B
$247K ﹤0.01%
5,675
– –
PB icon
969
Prosperity Bancshares
PB
$8.97B
$247K ﹤0.01%
3,458
– –
PHO icon
970
Invesco Water Resources ETF
PHO
$2.01B
$243K ﹤0.01%
6,309
– –
SLF icon
971
Sun Life Financial
SLF
$46B
$243K ﹤0.01%
5,333
– –
NEOG icon
972
Neogen
NEOG
$2.62B
$242K ﹤0.01%
7,432
– –
BURL icon
973
Burlington
BURL
$23.2B
$241K ﹤0.01%
1,057
– –
GL icon
974
Globe Life
GL
$14.2B
$241K ﹤0.01%
2,299
– –
SPOT icon
975
Spotify
SPOT
$103B
$241K ﹤0.01%
1,619
– –
37 38
39
40 41

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q1 2020 Portfolio in Review

As of Q1 2020, Glenmede Trust held 3,173 positions worth $21.9B, unchanged from the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 3,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, unchanged from a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust added most to Interpace Biosciences, Inc. Common Stock in Q1 2020, an estimated $51.9K increase.
  • Glenmede Trust's biggest Q1 2020 reduction was Brookfield Infrastructure Partners, cutting an estimated $78.8K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q1 2020.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2020.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $21.9B.

Based on Glenmede Trust's 13F filing for Q1 2020, filed 20 May 2020.